Atezolizumab is an immune checkpoint inhibitor, specifically a programmed death receptor ligand 1 (PD-L1) blocking antibody. It binds to PD-L1 on tumor cells and tumor-infiltrating immune cells, blocking its interaction with programmed death receptor 1 (PD-1) and B7.1 receptors, thereby lifting the suppression of tumor cells on the immune system, so that the immune system can better recognize and kill tumor cells.
Product Name: Atezolizumab
Concentration: 60mg/ml
CAS:1380723-44-3
Quantity:10mg, 50mg, 100mg.
苏州锦骊生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
张经理